SMTL ID : 6t5u.2 (1 other biounit)

KRasG12C ligand complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.72 Å

Oligo State

monomer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 3 residues within 4Å: Chain A: S.18, D.58 Ligands: GDP.2 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:S.18, H2O.1, H2O.1, H2O.1, H2O.1

1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)

GDP.2: 21 residues within 4Å: Chain A: A.12, G.14, V.15, G.16, K.17, S.18, A.19, F.29, V.30, D.31, E.32, Y.33, N.117, K.118, D.120, L.121, S.146, A.147, K.148 Ligands: MG.1, MKW.3 20 PLIP interactions: 20 interactions with chain A Hydrogen bonds: A:G.14, A:V.15, A:G.16, A:K.17, A:S.18, A:A.19, A:V.30, A:E.32, A:N.117, A:K.118, A:K.118, A:S.146, A:A.147, A:K.148 Water bridges: A:S.18 Salt bridges: A:K.17, A:D.120 pi-Stacking: A:F.29, A:F.29 pi-Cation interactions: A:K.118

1 x MKW: 1-[(7R)-16-chloro-15-(5-methyl-1H-indazol-4-yl)-9-oxa-2,5,12-triazatetracyclo[8.8.0.02,7.013,18]octadeca-1(10),11,13,15,17-pentaen-5-yl]prop-2-en-1-one(Covalent)

MKW.3: 20 residues within 4Å: Chain A: G.11, C.13, K.17, P.35, T.59, A.60, G.61, Q.62, E.63, E.64, Y.65, S.66, R.69, D.70, M.73, H.96, Y.97, Q.100, R.103 Ligands: GDP.2 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:Y.65, A:Y.97, A:Y.97, A:Q.100 Hydrogen bonds: A:K.17, A:E.64, A:S.66, A:Y.97, A:R.103 Water bridges: A:C.13

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kettle, J.G. et al., Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C. J.Med.Chem. (2020)

Release Date

2020-02-19

Peptides

V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, isoform CRA_b: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, isoform CRA_b

Related Entries With Identical Sequence